AU2001281465A1 - Treatment of rosacea - Google Patents
Treatment of rosaceaInfo
- Publication number
- AU2001281465A1 AU2001281465A1 AU2001281465A AU8146501A AU2001281465A1 AU 2001281465 A1 AU2001281465 A1 AU 2001281465A1 AU 2001281465 A AU2001281465 A AU 2001281465A AU 8146501 A AU8146501 A AU 8146501A AU 2001281465 A1 AU2001281465 A1 AU 2001281465A1
- Authority
- AU
- Australia
- Prior art keywords
- rosacea
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241001303601 Rosacea Species 0.000 title 1
- 201000004700 rosacea Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2301336 | 2000-03-17 | ||
| CA002301336A CA2301336A1 (en) | 2000-03-17 | 2000-03-17 | Topical treatment of rosacea |
| PCT/CA2001/000358 WO2001068675A2 (en) | 2000-03-17 | 2001-03-19 | Treatment of rosacea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001281465A1 true AU2001281465A1 (en) | 2001-09-24 |
Family
ID=4165558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001281465A Abandoned AU2001281465A1 (en) | 2000-03-17 | 2001-03-19 | Treatment of rosacea |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7153826B2 (en) |
| AU (1) | AU2001281465A1 (en) |
| CA (1) | CA2301336A1 (en) |
| WO (1) | WO2001068675A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2408263A (en) * | 2003-11-14 | 2005-05-25 | Pacgen Biopharmaceuticals Inc | Antimicrobial peptides with reduced hemolysis and methods of their use. |
| US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
| CN101906138B (en) * | 2010-07-13 | 2012-10-17 | 暨南大学 | A kind of pseudocyclic polypeptide and its synthesis method and application |
| CN101906149B (en) * | 2010-07-13 | 2012-10-17 | 暨南大学 | A kind of linear polypeptide and its synthesis method and application |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128617A (en) * | 1982-10-06 | 1984-05-02 | Martti Vaara | Polypeptides for use in antibacterial therapy |
| US5998200A (en) * | 1985-06-14 | 1999-12-07 | Duke University | Anti-fouling methods using enzyme coatings |
| DE4328871A1 (en) | 1993-08-27 | 1995-03-02 | Beiersdorf Ag | Means against sensitive, hyper-reactive skin conditions, atopic dermatitis, pruritus, psoriasis prurigo, photodermatoses and ichthyosis |
| US5587358A (en) * | 1994-05-09 | 1996-12-24 | Asahi Kasei Kogyo Kabushiki Kaisha | Potentiators of antimicrobial activity |
| FR2732221B1 (en) * | 1995-03-28 | 1997-04-25 | Oreal | USE OF A CGRP ANTAGONIST TO TREAT CUTANEOUS REDNESS OF NEUROGENIC ORIGIN AND COMPOSITION OBTAINED |
| WO1998004584A1 (en) * | 1996-07-26 | 1998-02-05 | Seatek Marine Biotechnology, Inc. | Cyclic decapeptide antibiotics |
| MXPA02006029A (en) * | 1999-12-15 | 2004-08-23 | Cubist Pharm Inc | Novel lipopeptides as antibacterial agents. |
| CA2394313A1 (en) * | 1999-12-15 | 2001-06-21 | Cubist Pharmaceuticals, Inc. | Novel lipopeptides as antibacterial agents |
| US6696412B1 (en) * | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
-
2000
- 2000-03-17 CA CA002301336A patent/CA2301336A1/en not_active Abandoned
-
2001
- 2001-03-19 WO PCT/CA2001/000358 patent/WO2001068675A2/en not_active Ceased
- 2001-03-19 AU AU2001281465A patent/AU2001281465A1/en not_active Abandoned
- 2001-03-19 US US10/221,933 patent/US7153826B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7153826B2 (en) | 2006-12-26 |
| WO2001068675A2 (en) | 2001-09-20 |
| WO2001068675A3 (en) | 2001-12-13 |
| US20040023857A1 (en) | 2004-02-05 |
| CA2301336A1 (en) | 2001-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002223827A1 (en) | Well treatment | |
| AU2002257936A1 (en) | Methods of well treatment | |
| AUPR406501A0 (en) | Treatment of vault prolapse | |
| AU2002215125A1 (en) | Well treatment method | |
| AU2001286983A1 (en) | Method of treatment | |
| AU2001247841A1 (en) | Medical procedure | |
| AU2002231206A1 (en) | Treatment of depression | |
| AU2002319286A1 (en) | Skin treatment | |
| AUPR731901A0 (en) | Method of treatment | |
| AU2001257325A1 (en) | Cancer treatment | |
| AU2001245414A1 (en) | Treatment of allergies | |
| AU2002335667A1 (en) | Modified reoviral therapy | |
| AU2001281465A1 (en) | Treatment of rosacea | |
| AU1618901A (en) | Treatment of rosacea | |
| AU2001262177A1 (en) | Method of treatment | |
| AU2001253560A1 (en) | Methods of treatment | |
| AU2001289127A1 (en) | Tumor treatment | |
| AU2001257168A1 (en) | Cancer treatment | |
| AUPR814901A0 (en) | Water treatment | |
| HK1056502A (en) | Methods of treatment | |
| AU2001250000A1 (en) | Treatment of vitiligo | |
| AU2002226380A1 (en) | Tissue treatment | |
| AUPR213000A0 (en) | Method of treatment | |
| AUPQ662500A0 (en) | Method of treatment | |
| AUPQ949500A0 (en) | Method of treatment |